Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RSMDF) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Resmed (RSMDF) over the last 9 years, with Q4 2025 value amounting to $5.9 million.

  • Resmed's Restructuring Costs changed N/A to $5.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.8 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2025, which is 9683.78% down from last year.
  • Resmed's Restructuring Costs amounted to $5.9 million in Q4 2025.
  • In the past 5 years, Resmed's Restructuring Costs ranged from a high of $64.2 million in Q4 2023 and a low of $1.8 million during Q2 2023
  • Over the past 3 years, Resmed's median Restructuring Costs value was $5.9 million (recorded in 2025), while the average stood at $14.3 million.
  • Data for Resmed's Restructuring Costs shows a peak YoY increase of 66352.83% (in 2023) and a maximum YoY decrease of 568.42% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows Resmed's Restructuring Costs stood at $8.4 million in 2022, then skyrocketed by 663.53% to $64.2 million in 2023, then crashed by 90.76% to $5.9 million in 2025.
  • Its Restructuring Costs stands at $5.9 million for Q4 2025, versus $15.8 million for Q3 2025 and $2.0 million for Q2 2025.